Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional methotrexate and triamcinolone acetonide are more effective than Vitamin D3 for treating alopecia areata.

The TO-TF copolymer strengthens damaged hair effectively and sustainably.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Shell ginger contains kavalactones that promote hair growth and have anti-cancer, anti-inflammatory, and anti-obesity effects.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Pilomatrixoma involves abnormal hair keratin production and cell death, causing debris and cysts.

The combination of Typhonium flagelliforme extract and natural interferons effectively reduces tumor growth in mice.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Thioglycolic acid mainly affects the unordered areas in hair structure.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

The serum with microneedling device improves hair loss treatment effectively and safely.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Activating TRPV3 reduces skin oil production and increases inflammation, potentially causing dry skin issues.

The analysis of a large pilomatricoma revealed five distinct areas with different gene activity related to hair growth and tumor development.

Using a special skin cream with gabapentin helped reduce symptoms of a certain scalp condition but didn't change nerve fibers or skin chemicals.

A pilomatrixoma in the eyebrow can cause hair loss and skin lightening.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Intralesional steroid therapy is useful for treating various skin conditions.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Monilethrix is a genetic disorder causing brittle hair, diagnosed using tricoscopy.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

A painless cheek lump was misdiagnosed but later identified as a rare benign skin lesion called pilomatrixoma.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Hair loss lotion with specific ingredients effectively improves hair growth and thickness safely.